Our data support these findings, showing that the presence of IL-13, specifically derived from ILC2s, significantly enhances the migratory and invasive behavior of PCa cells, underscoring the potential of targeting this cytokine pathway for therapeutic intervention in PCa. This evidence concerns the gene IL13 and posterior cortical atrophy.